Cómo citar
1.
El futuro de las vacunas de mRNA para las enfermedades autoinmunes. Rev. parag. reumatol. [Internet]. 2021 Dec. 15 [cited 2025 Sep. 13];7(2):32-3. Available from: https://revista.spr.org.py/index.php/spr/article/view/139
Referencias
(1) Sahin U, Karikó K, Türeci Ö. mRNA-based therapeutics-developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759–80.
(2) Cai X, Li JJ, Liu T, Brian O, Li J. Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design. Brief Funct Genomics. 2021;20(5):289–303.
(3) Krienke C, Kolb L, Diken E, Streuber M, Kirchhoff S, Bukur T, et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science. 2021;371(6525):145-
(4) Serra P, Santamaria P. Antigen-specific therapeutic approaches for autoimmunity. Nat Biotechnol. 2019;37(3):238–51.
(5) Wardell C, Levings, M. mRNA vaccines take on immune tolerance. Nat Biotechnol. 2021;39(4):419–21.
Descargas
##plugins.themes.healthSciences.displayStats.noStats##